DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories Limited
02 1Dr. Reddy¿s Laboratories Limited
03 1Metrochem API Private Limited
04 1Cohance Lifesciences Limited
05 1USV Private Limited
06 1Aurobindo Pharma Limited
07 1Bidachem S.p.a.
08 1Biocon Limited
09 1Boehringer Ingelheim Pharma GmbH and Co. KG
10 1Cipla Ltd.
11 1Dr. Reddy's Laboratories Ltd.
12 1EMNAR PHARMA PRIVATE LIMITED
13 2Honour Lab Limited
14 2MSN Life Sciences Private Limited
15 1Qingdao Biopeptek Co., Ltd.
16 1SMS Pharmaceuticals Limited
17 1Tianish Laboratories Private Limited
18 2ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
01 18Empagliflozin
02 1Empagliflozin (Process II)
03 3Empagliflozin Amorphous
01 2China
02 1Germany
03 16India
04 1Italy
05 1U.S.A
06 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 71796-001
Start Marketing Date : 2018-01-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
NDC Package Code : 42765-016
Start Marketing Date : 2020-10-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 76072-1015
Start Marketing Date : 2019-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USV offers custom peptide synthesis ranging from gram to multi-gram to multi-kilogram quantities.
NDC Package Code : 62147-0289
Start Marketing Date : 2024-12-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 71796-064
Start Marketing Date : 2022-12-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 71796-048
Start Marketing Date : 2022-03-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-179
Start Marketing Date : 2023-11-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51869-0015
Start Marketing Date : 2016-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12714-201
Start Marketing Date : 2016-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7723
Start Marketing Date : 2024-04-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
46
PharmaCompass offers a list of Empagliflozin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Empagliflozin manufacturer or Empagliflozin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Empagliflozin manufacturer or Empagliflozin supplier.
PharmaCompass also assists you with knowing the Empagliflozin API Price utilized in the formulation of products. Empagliflozin API Price is not always fixed or binding as the Empagliflozin Price is obtained through a variety of data sources. The Empagliflozin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Empagliflozin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Empagliflozin, including repackagers and relabelers. The FDA regulates Empagliflozin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Empagliflozin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Empagliflozin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Empagliflozin supplier is an individual or a company that provides Empagliflozin active pharmaceutical ingredient (API) or Empagliflozin finished formulations upon request. The Empagliflozin suppliers may include Empagliflozin API manufacturers, exporters, distributors and traders.
click here to find a list of Empagliflozin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Empagliflozin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Empagliflozin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Empagliflozin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Empagliflozin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Empagliflozin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Empagliflozin suppliers with NDC on PharmaCompass.
We have 16 companies offering Empagliflozin
Get in contact with the supplier of your choice:
